How much did Almirall achieve in EBIT for the current year?
In the current year, Almirall has achieved an EBIT of 72.01 M EUR.
Almirall EBIT 2024
Almirall EBIT
72.01 M EUR
Ticker
ALM.MC
ISIN
ES0157097017
WKN
A0MU8Y
In 2024, Almirall's EBIT was 72.01 M EUR, a 78.18% increase from the 40.42 M EUR EBIT recorded in the previous year.
The Almirall EBIT history
| YEAR | EBIT (undefined EUR) |
|---|---|
| 2028e | 171.18 |
| 2027e | 142.31 |
| 2026e | 154.44 |
| 2025e | 109.48 |
| 2024e | 72.01 |
| 2023 | 40.42 |
| 2022 | 54.62 |
| 2021 | 102.39 |
| 2020 | 103.06 |
| 2019 | 107.94 |
| 2018 | 56.56 |
| 2017 | -54.58 |
| 2016 | 62.23 |
| 2015 | 83.14 |
| 2014 | -2.6 |
| 2013 | 6.3 |
| 2012 | 55.3 |
| 2011 | 96.9 |
| 2010 | 154.4 |
| 2009 | 179.1 |
| 2008 | 165.8 |
| 2007 | 134.1 |
| 2006 | 115.4 |
| 2005 | 128.4 |
| 2004 | 108.7 |
Almirall Aktienanalyse
What does Almirall do?
The company Almirall SA is a globally operating pharmaceutical company headquartered in Barcelona, Spain. Founded in 1943 by Antonio Gallardo Ballart, the company has since become one of the leading companies in the field of dermatology and respiratory diseases. Almirall specializes in the development, manufacturing, and marketing of medications used in the treatment of skin conditions such as psoriasis or eczema, as well as respiratory diseases such as asthma or chronic bronchitis. The company focuses on close collaboration with doctors and patients to achieve the best possible therapeutic success. Almirall's business model is based on collaboration with other pharmaceutical companies to develop and bring innovative medications to the market. The company has its own research and development departments and also conducts clinical trials to test the safety and efficacy of new medications. Additionally, Almirall operates its own network of distribution and marketing partners to distribute its products worldwide. Almirall is organized into three divisions: dermatology, respiratory diseases, and other therapeutic areas. The dermatology division includes the development and marketing of medications for the treatment of skin conditions such as psoriasis and eczema. Some examples of products in this division are Skilarence, a medication for the treatment of moderate to severe psoriasis, and Kigozi, a topical medication for the treatment of atopic dermatitis. The respiratory diseases division includes the development and marketing of medications for the treatment of asthma and chronic bronchitis. The company offers a wide range of medications in this area that can be used in inhalation or tablet therapy. Some of the well-known products in this division are Alvesco, an inhaled corticosteroid for the treatment of asthma, and Ebastel, a medication for the treatment of allergic reactions. In other therapeutic areas, Almirall is involved in the development of new medications for the treatment of diseases such as ulcerative colitis or schizophrenia. For example, the company has developed Sativex, a cannabis-based medication for the treatment of multiple sclerosis-related spasticity, which is already approved in several countries. Throughout its history, Almirall has received numerous awards and recognition, including for the development of innovative medications and its work in the field of sustainability and corporate social responsibility. Through its commitment to research and development and collaboration with other pharmaceutical companies, Almirall will continue to play an important role in the global pharmaceutical industry market. Almirall ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Almirall's EBIT
Almirall's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Almirall's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Almirall's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Almirall’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Almirall Stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Almirall.
How has the EBIT of Almirall developed in recent years?
The EBIT of Almirall has increased by 78.176% increased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Almirall?
The EBIT of Almirall is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Almirall pay?
Over the past 12 months, Almirall paid a dividend of 0.18 EUR . This corresponds to a dividend yield of about 1.92 %. For the coming 12 months, Almirall is expected to pay a dividend of 0.18 EUR.
What is the dividend yield of Almirall?
The current dividend yield of Almirall is 1.92 %.
When does Almirall pay dividends?
Almirall pays a quarterly dividend. This is distributed in the months of June, June, June, June.
How secure is the dividend of Almirall?
Almirall paid dividends every year for the past 14 years.
What is the dividend of Almirall?
For the upcoming 12 months, dividends amounting to 0.18 EUR are expected. This corresponds to a dividend yield of 1.9 %.
In which sector is Almirall located?
Almirall is assigned to the 'Health' sector.
Wann musste ich die Aktien von Almirall kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Almirall from 6/12/2024 amounting to 0.184 EUR, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.
When did Almirall pay the last dividend?
The last dividend was paid out on 6/12/2024.
What was the dividend of Almirall in the year 2023?
In the year 2023, Almirall distributed 0.186 EUR as dividends.
In which currency does Almirall pay out the dividend?
The dividends of Almirall are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Almirall
Our stock analysis for Almirall Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Almirall Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
